Why the study?
The effect of preoperative internal medicine evaluations on cancer patients undergoing surgery was uncertain.
Does a preoperative internal medicine evaluation reduce 30-day mortality in cancer patients undergoing surgery?
Does a preoperative internal medicine evaluation reduce 30-day mortality in cancer patients undergoing surgery?
Preoperative internal medicine evaluation is associated with a significantly lower 30-day postoperative mortality risk in cancer patients.
Preoperative IM evaluation was associated with lower 30-day mortality after cancer surgery; hypothesis-generating and should not change practice without RCTs.
Background The effect of preoperative internal medicine evaluations on cancer patients undergoing surgery is uncertain. Methods We conducted a retrospective cohort study of cancer patients who had been included in the National Surgery Quality Improvement Program from 2011–2014 to determine the effect of an Internal Medicine Perioperative Assessment Center (IMPAC) evaluation on the risk of 30-day mortality compared to that of patients who proceeded directly to surgery. Results Of the 11,577 participants, 3589 underwent an IMPAC evaluation. Among the propensity score-matched cohorts, the odds ratio (OR) of 30-day mortality was .39 (95% CI = .18-.84). Conclusions Our findings demonstrate that a preoperative internal medicine evaluation was associated with lower 30-day mortality.
No takes yet. Share an insight, caveat, or question.
Soones et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: